A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease

Proteomic Identification of Early Biomarkers of Acute Kidney Injury After Cardiac Surgery in Children

(2010) Prasad Devarajan et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker

(2010) Lei Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Integrated multi-level quality control for proteomic profiling studies using mass spectrometry

(2009) David A Cairns et al.   BMC BIOINFORMATICS

Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma

(2009) N S Vasudev et al.   BRITISH JOURNAL OF CANCER

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective

(2009) Peter Findeisen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Application of proteomic analysis to the study of renal diseases

(2009) Matthew P. Welberry Smith et al.   Nature Reviews Nephrology

Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model

(2009) Vassilis Aggelis et al.   PROTEOMICS

Beta2-Microglobulin

(2009) Tilman B. Drüeke et al.   SEMINARS IN DIALYSIS

Serum  2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients

(2008) S. Okuno et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Urinary proteomic analysis of chronic allograft nephropathy

(2008) Edmond O'Riordan et al.   Proteomics Clinical Applications

Proteomic profiling using mass spectrometry – does normalising by total ion current potentially mask some biological differences?

(2007) David A. Cairns et al.   PROTEOMICS